Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7484.074 | 0.6012 | 0.6462 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7484.074 | 0.4544 | 0.4790 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7484.074 | 0.4544 | 0.4790 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7484.074 | 0.1848 | 0.0483 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7484.074 | 0.1848 | 0.0483 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7484.074 | 0.0053 | -0.7316 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7484.074 | 0.0053 | -0.7316 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7485.074 | 1.0573 | 1.0317 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7485.074 | 1.0573 | 1.0317 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7485.074 | 0.9902 | 0.9944 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7485.074 | 0.9902 | 0.9944 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7485.074 | 0.9813 | 0.9894 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7485.074 | 0.9813 | 0.9894 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7485.074 | 1.0728 | 1.0401 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7485.074 | 1.0728 | 1.0401 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7485.074 | 0.7358 | 0.8340 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7485.074 | 0.7358 | 0.8340 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7485.074 | 0.3669 | 0.5068 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7485.074 | 0.3669 | 0.5068 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7485.074 | 0.1759 | 0.2243 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7485.074 | 0.1759 | 0.2243 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7485.074 | 0.0099 | -0.4562 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7485.074 | 0.0099 | -0.4562 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7485.074 | 0.0072 | -0.5031 | 3.5413 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7485.074 | 0.0072 | -0.5031 | 3.5413 |